Galectin Therapeutics
GALT
#7673
Rank
NZ$0.63 B
Marketcap
NZ$9.89
Share price
4.83%
Change (1 day)
197.43%
Change (1 year)

Galectin Therapeutics (GALT) - Total assets

Total assets on the balance sheet as of June 2025 : NZ$26.82 Million

According to Galectin Therapeutics's latest financial reports the company's total assets are NZ$26.82 Million. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Galectin Therapeutics - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31NZ$31.02 M-30.43%
2023-12-31NZ$44.59 M33.01%
2022-12-31NZ$33.52 M-45.25%
2021-12-31NZ$61.23 M49.27%
2020-12-31NZ$41.02 M-43%
2019-12-31NZ$71.96 M436%
2018-12-31NZ$13.42 M129.16%
2017-12-31NZ$5.85 M-74.31%
2016-12-31NZ$22.8 M-40.9%
2015-12-31NZ$38.58 M1.87%
2014-12-31NZ$37.87 M190.54%
2013-12-31NZ$13.03 M12.17%
2012-12-31NZ$11.62 M37.19%
2011-12-31NZ$8.47 M3.75%
2010-12-31NZ$8.16 M1260.36%
2009-12-31NZ$0.6 M-50.52%
2008-12-31NZ$1.21 M-47.85%
2007-12-31NZ$2.32 M-74.24%
2006-12-31NZ$9.03 M24.39%
2005-12-31NZ$7.26 M-53.36%
2004-12-31NZ$15.56 M26.48%
2003-12-31NZ$12.3 M182.17%
2002-12-31NZ$4.36 M2.55%
2001-12-31NZ$4.25 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Mirati Therapeutics
MRTX
NZ$1.94 B 7,140.80%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
NZ$0.85 B 3,070.36%๐Ÿ‡บ๐Ÿ‡ธ USA